Diagnosis and Treatment of Pediatric Cardiomyopathy

Abstract

Childhood-onset idiopathic cardiomyopathy is relatively rare, and its management requires sufficient knowledge and expertise of pediatric cardiologists. This review article was based on the presentations at the 20^th Educational Seminar Basic Course of the Japanese Society of Pediatric Cardiology and Cardiac Surgery on July 8, 2023. First, this review provided an overview of recent pharmacotherapy strategies for heart failure according to adult guidelines published in the US, Europe, and Japan. Subsequently, it delved into the clinical assessment and treatment of specific topics, including dilated cardiomyopathy, hypertrophic cardiomyopathy, and restrictive cardiomyopathy. Finally, it briefly introduced the current status of pediatric heart transplantation in Japan and our hospital.